PPT-Supplementary Figures Supplemental Figure 1

GSE47460GPL14550 GSE47460GPL6480 Supplemental Figure 2 Megakaryocyte score Platelet score FVC DLCO A B Megakaryocyte score Platelet score FVC DLCO r 009331 p 05237 r 007781 p 06721. Supplementary Figure . 2A:. . T-wave morphology changes upon stand-up test in LQTS . patients according to genotype. . Leads. – II, III, aVF. . Supplementary Figure . 2B:. . T-wave morphology changes upon stand-up test in LQTS patients according to . washed repeatedly in PBS and PBS containing 0.3% Triton X-100 (PBS/Triton), and then incubated in blocking buffer (5% normal goat serum, 0.2% cold white fish skin gelatin, PBS/Triton) for 1 hour. Sections were then incubated with mouse anti-tyrosine hydroxylase (1:1000; Millipore; Billerica, MA) for 48 hours at 4°C. They were subsequently washed five times in PBS/Triton before being incubated with . . . Somatic mutation spectrum. # Substitutions. # Substitutions per Mb. b. c. a. # Substitutions per Mb. Repeats. Pseudogenes. Whole genome. Splice sites. Non-coding RNA. Intron. Promoter. 5’ UTR. 3’ UTR. 3 Provenance One document describing the provenance of this figure is available This is a handwritten note in ink on lined paper that was provided to one artefacts AM 8891- 8903 from Malaita in the Sections Section 1 Formatting Figures within the Thesis or Dissertation p 2Information in this manual has been modified fromx0000x0000Updated by GC SST Summer 20212Section 1 Formatting Figures within YIV-906. (500mg/kg . p.o.. bid . x7. days) plus different dose of anti-PD1 . (70ug or 200ug/mice . i.p. . once) . against . Hepa. 1-6 in vivo.. Tumor size at the beginning were about . 270mm. 3. Analysis . of the CDK4/6 Cell-Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib . Michael . J. Böhm. 1. , Ralf Marienfeld. 1. , Daniela Jäger. 1. , Kevin Mellert. E. F. A. C. D. APCMin. /+. APCMin. /+/C3aR-/-. APCMin. /+/C3aR-/-. APCMin. /+. APCMin. /+. APCMin. /+/C3aR-/-. APCMin. /+. APCMin. /+/C3aR-/-. APCMin. /+/C3aR-/-. APCMin. /+. APCMin. /+. APCMin. /+/C3aR-/-. Viral infection. Inflammation response. -log10(. p. -value) -log10(. A.. B.. Supplemental Figure 3. Control. α-synuclein. Vehicle. Nicotine. A.. B.. C.. D.. No RNAi. SV2L1 KD. SV2L2 KD. B. Supplemental Figure 2. Tissue. Adrenal gland . Appendix. Appendix . Bone marrow . Breast . Breast cancer. Bronchus Respiratory . Cartilage. Cerebellum . Cerebellum . Cerebellum . Cerebral cortex. Cerebral cortex. children . aged 2–5 years . in Medicaid receiving . clinical care for . attention-deficit/hyperactivity disorder (ADHD): United States, 2011. 0.45-1.40%. 1.41-1.70%. 1.71-2.05%. 2.06-3.38%. SUPPLEMENTAL FIGURE 5. . Consort flow chart summarizing the number of patients screened, enrolled, treated and followed on the study. *one patient was re-assessed for eligibility at recurrence and re-enrolled on the study. Created with BioRender.com.. PsaM. proteins. Blue mark indicate conservation of amino acids below 90%.. Supplementary Figure 2. . (A) Phylogenetic tree of . PsaM. genes showing five clusters (mentioned as 1, 2, 3, 4, and 5). (B).